Your SlideShare is downloading. ×
Relevant Stage 4 Cancer Solutions
Relevant Stage 4 Cancer Solutions
Relevant Stage 4 Cancer Solutions
Relevant Stage 4 Cancer Solutions
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Relevant Stage 4 Cancer Solutions

218

Published on

http://www.envita.com/conditions-we-treat/cancer/stage-4cancer/ - Stage 4 Cancer is also known as Stage IV Cancer, which spread to various sites in the body. It is a complex type of cancer to treat, …

http://www.envita.com/conditions-we-treat/cancer/stage-4cancer/ - Stage 4 Cancer is also known as Stage IV Cancer, which spread to various sites in the body. It is a complex type of cancer to treat, and it can involve many organ systems. Envita’s vast area of technologies options gives stage 4 cancer patients the most complete approach to their cancer.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
218
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Relevant Stage 4 Cancer SolutionsAs technology and our knowledge base continues to grow, it becomes more importantthan ever to learn what is present in the realm of modern-day cancer treatments – inparticular, the availability of new techniques to deal with advanced and stage 4 cancer.An article on the United States’ website HealthReport.gov explains, "Nearly one out oftwo Americans born today will be diagnosed with cancer at some point in their lifetime."Moreover, “About 1,596,670 new cancer cases are expected to be diagnosed in 2011 -about 571,950 Americans are expected to die of cancer, more than 1,500 people a day– and cancer is the second most common cause of death in the US, exceeded only byheart disease. In the US, cancer alone accounts for nearly 1 of every 4 deaths," reportsthe *American Cancer Society.Amid these turbulent seas, there is a powerful treatment with which to approach stage 4cancer called anti-angiogenic therapy. It works by starving the cancer cells fromnutrients, thereby impeding its growth and spread.It is reported that nearly 90 percent of cancer patients succumb when their cancermetastasizes – the calling card of stage 4 cancer. Angiogenesis is the process bywhich tumors grow by attracting blood vessels to “nourish” themselves. However, atechnique exists to thwart these very processes. With newly developed modern
  • 2. “alternative” medicines, both metastasis and angiogenesis can be impeded or evensubjugated. Envita leads the domestic pack by currently offering such integrative and uniqueprocesses. There is no denying that patients benefit from an anti-angiogenic approachto supplement most traditional chemotherapy regimes. Through rigorous tests andanalysis, Envita recommends and implements strategies that will work synergisticallywith the body to enhance the ultimate goal of patient health and well-being.With these great developments, it is important to give credit where credit is due. Theorigin of this research field began with Judah Folkman, who realized that a tumor placedin a lab container had only a limited potential for growth, establishing that its microvascular network was being disrupted.In the early days of his papers, 1964 to 1989, his findings were largely overlooked bymany. While they agreed that there was evidence of newly forming vessels, theassumption was that the smaller, weaker cell networks were merely a side effectassociated with the dying tumor cells. Eventually, Folkman could prove that the newvessels were actually being fashioned by the cancer cells themselves as a means ofsupplemental nourishment.In hindsight, it is something of an embarrassment that Dr. Folkman was treated the wayhe was in the early days of his findings. In an industry so overcome by a poor track-record, one would think that innovators, free thinkers, and pioneers would be eagerlywelcomed to the table. Unfortunately, cancer research, like so many other fields, seemsto harbor the same common pattern of contempt for the new and unknown.Another such example of this contemptuous foolery came when Don Ingber found that afungus contaminated some of his endothelial cell test samples, which caused theirgrowth to cease. Of course, Inber was ignored and treated like a quack, until later it wasproven that angiogenesis could, in fact, be inhibited.Today, anti-angiogenic drugs such as sorafenib (Nexavar®), sunitinib (Sutent®),pazopanib (Votrient®), and everolimus (Afinitor®) are typically prescribed in late-stagecancers in order to impeded growth. That being said, a simple agent like oxygen (notpatentable) is an oft overlooked. To put it mildly, oxygen is nothing less than a dominantanti-angiogenic agent. Oxygen becomes an important agent for stage 4 cancertreatment.In fact, errors occurring in oxygen metabolism are often at the root of cancer causes aswell as their continued development. Moreover, understanding the role of oxygen andcorrectly administering it can be vital for success in stage 4 cancer cases.
  • 3. It is no secret that cancer cells rely upon a blood supply to spread. So, it stands toreason that angiogenesis should be blocked to stop tumor growth. Virtually, all tumorsdemand an unending supply of nutrients supplied via blood to continue to spread.Without such supplies, tumor growth is limited to a manageable 2 mm.In stage 4 cancer cases, it is a lack of oxygen that ultimately feeds growth and spread.The introduction of vascular endothelial growth factor (VEGF) to angiogenesis, a criticalprocess, actually occurs because of hypoxia – the absence of oxygen. Transcriptionalfactor HIF-1 (hypoxia inducible factor 1) allows this process to materialize.There is always a need for hypoxic tissue on tumors to promote the release of VEGF -as they invariably aim to grow beyond the limits of the blood supply. Should we dedicateone chemotherapy treatment to block VEGF, we could then target ways to improve thetumor’s oxygen metabolism.Tumors cannot grow or spread without VEGF. By enhancing the body’s ability to carryoxygen and employing other cancer-killing methods simultaneously, Envita is creatingnew approaches to eliminate cancer and the processes that allow for their developmentand growth. One secret is the ability to create an environment that is unwelcome tostage 4 cancer cells.And there is more good news, now that we know that precarious blood cells are anexcellent way to target cancers. Released VEGF binds to the endothelial cells of nearbyvessels, and subsequently, they begin to break up and grow in the direction of the tumorin an effort to bring new vessels to feed it. These inferior vessels are relatively easy todetect through photodynamic protocols, which means they can be isolated and attackedwhile simultaneously strengthening healthy vessels throughout the body.Research shows that VEGF is connected with a series of tumor types, including breast,ovarian, cervical, esophageal, lung, and cervical cancer, as well as glioblastomamultiforme and renal cell carcinoma. It would seem that VEGF emissions may alsohinder the immune system’s ability to react and fight off the tumor - regularly occurringin stage 4 cancers.One thing to keep in mind is that the immune system is the first and last defense againststage 4 cancer. More than 90 percent of all cancer patients die because of metastasis, acritical component for stage 4 cancer – the very process by which cancer cells canspread into the blood supply and be dispersed throughout the body. Sadly, manypatients believe their cancer had been eradicated, only to discover later about dormantmetastasis and why cancer comes back often at stage 4. For this reason, it isimperative to correct the body’s metabolism for oxygen and put a stop to angiogenesis.
  • 4. For more information and articles on stage 4 cancer treatments, contact or visit us atEnvita’s website. If you know anyone who has been diagnosed with cancer, pleaseforward this article to them. We welcome you to contact us with questions and invite youto watch informative videos. You can also visit our PPMR section to learn more aboutthe power of Envita’s personalized medicine (link to Envita PPMR page) for stage 4cancer (link Envita cancer page) and chronic diseases. It is important information thatmay save lives. Education is the best prescription.Envita’s Comprehensive Smart Oncology uses the foremost of oncology in combinationwith aggressive natural therapies to help a patient reach better health.References:*Judah Folkman <http://www.pbs.org/wgbh/nova/body/cancer-warrior.html > , <http://en.wikipedia.org/wiki/Judah_Folkman > *Stage 4 Cancer <http://en.wikipedia.org/wiki/Stage-4_cancer#Systems_of_staging > * Vascularendothelial growth factor<http://en.wikipedia.org/wiki/Vascular_endothelial_growth_factor>*HealthReform.gov<http://www.healthreform.gov/reports/fightingcancer/index.html>*American CancerSociety<http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf>

×